Showing results (11-20 of 2,687) with videos related to
Sort By:
Pageof 269
British Journal of Pharmacology|June 5, 2023
A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CBLiang Yang, Xiao Zhu, David B Finlay, et al.Seminars in Dialysis|April 24, 2009
Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate?Stacey O'Shea, Stephen Duffull, David W JohnsonPharmaceutical Statistics|March 14, 2012
A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studiesLee Kien Foo, James McGree, Stephen DuffullBritish Journal of Clinical Pharmacology|September 4, 2020
A minimal model to describe short-term haemodynamic changes of the cardiovascular systemSalma Bahnasawy, Hesham Al-Sallami, Stephen DuffullNaunyn-Schmiedeberg'S Archives of Pharmacology|January 16, 2024
Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical modelHayley M Green, Liang Yang, Xiao Zhu, et al.International Journal of Clinical Pharmacy|February 24, 2012
General practitioners' perceptions of pharmacists' new services in New ZealandErnieda Hatah, Rhiannon Braund, Stephen Duffull, et al.Clinical Pharmacokinetics|October 31, 2020
The Influence of Haemostatic System Maturation on the Dose-Response Relationship of Unfractionated HeparinAbdallah Derbalah, Stephen Duffull, Katie Moynihan, et al.Journal of Biopharmaceutical Statistics|October 19, 2012
Comparison of robust criteria for D-optimal designsLee Kien Foo, James McGree, John Eccleston, et al.Vitamins and Hormones|August 4, 2009
Anandamide receptor signal transductionCatherine E Goodfellow, Michelle GlassCurrent Opinion in Pharmacology|November 16, 2024
Could positive allosteric modulators of the cannabinoid CB<sub>1</sub> receptor be efficacious and safe for the treatment of chronic pain?Hayley M Green, Michelle GlassPageof 269